EIF4A3-IN-7

• Description :

  EIF4A3-IN-7 is a potent inhibitor of eIF4A3. eIF4A3-IN-7 has the potential for researching cancer and other dysproliferative diseases (extracted from patent WO2019161345A1, Compound 8) [1].

• UNSPSC :

  12352005

• Target :

  Eukaryotic Initiation Factor (eIF)

• Type :

  Reference compound

• Related Pathways :

  Cell Cycle/DNA Damage

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Assay Protocol :

  https://www.medchemexpress.com/eif4a3-in-7.html

• Solubility :

  10 mM in DMSO

• Smiles :

  O[C@]12[C@](OC3=CC(OC)=CC(OC)=C32)(C4=CC=C(C=C4)O)[C@@](C5=CC=CC=C5)([H])[C@H]([C@H]1O)C(N)=O

• Molecular Formula :

  C26H25NO7

• Molecular Weight :

  463.48

• References & Citations :

  [1]Yoshiyuki Fukase, et al. Agents and methods for treating dysproliferative diseases. Patent WO2019161345A1.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• Isoform :

  EIF4

• CAS Number :

  [2374759-82-5]